N. Tsapaeva, S. Zolotuhina, Е. Mironova, Е. Burakovskaja, A. Viarsotski
A cute myocardial infarction (AMI) is a starting point for the development of heart failure (HF), which increases the risk of death. The development of HF in AMI patients significantly worsens the prognosis and increases treatment costs, which determines the medical and social significance of the problem. This not only emphasizes the necessity of careful monitoring of AMI patients, but also is a reasonable motivation for the use of multimodal approach to determine the individual risk of heart failure development in patients with AMI, since different pathogenetic mechanisms with different contribution of leading disorders are involved in HF development: microcirculatory dysfunction, inflammation, hemorrhage, edema, remodeling. Multimodal approach is implemented by the identification of clinical, laboratory, angiographic and imaging predictors of HF development. For risk stratification it is necessary to substantiate the optimal combination of prognostic methods to determine the degree of heart failure development risk, the key pathogenetic mechanism of its development and, accordingly, to use the most adequate treatment regimens.
keywords: myocardial infarction, heart failure, radiation diagnostic methods, index of microcirculatory resistance
for references: N. Tsapaeva, S. Zolotuhina, Е. Mironova, Е. Burakovskaja, A. Viarsotski. A multimodal approach to heart failure risk assesment in patients with acute myocardial infarction (Part 2). Instrumental and imaging predictors). Neotlozhnaya kardiologiya i kardiovaskulyarnye riski [Emergency cardiology and cardiovascular risks], 2023, vol. 7, no. 1, pp. 1758–1767.
1. Steg P.G., Dabbous O.H., Feldman L.J., et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circul, 2004, vol. 109, pp. 494-499.
2. Smirnova M.D., Ageev F.T. Hronicheskaya serdechnaya nedostatochnost’ kak oslozhnenie infarkta miokarda: osobennosti terapii [Chronic heart failure as a myocardial infarction complication: therapy features]. RMZH. Medicinskoe obozrenie, 2019, vol. 3, no. 10(1), pp. 40-44. (in Russian).
3. Osipova O.A., Nagibina A.I., Komisov A.A., et al. Patomorfologicheskie mekhanizmy regulyacii obrazovaniya miokardialnogo fibroza u bolnyh hronicheskoj serdechnoj nedostatochnost’yu na fone ishemicheskoj bolezni serdca [Pathomorphological mechanisms of the regulation of the formation of myocardial fibrosis in patients
with chronic heart failure against ischemic heart disease]. Serdechnaja nedostatochnost, 2016, vol. 17(5), pp. 357-364. (in Russian).
4. Uskov V.M. Modelirovanie, algoritmizaciya i prognozirovanie iskhodov transmural’nogo infarkta miokarda pri razlichnyh skhemah medikamentoznoj terapii [Modeling, algorithmization and prediction of outcomes of transmural myocardial infarction with various schemes of drug therapy: thesis]. Voronezh. gos. tehn. un-t. Voronezh, 2004. (in Russian).
5. Revishvili A.Sh., Golitsyn S.P., Egorov D. F. Vserossijskie klinicheskie rekomendacii po kontrolyu nad riskom vnezapnoj ostanovki serdca i vnezapnoj serdechnoj smerti, profilaktike i okazaniyu pervoj pomoshchi [All-Russian clinical recommendations for the control of the risk of sudden cardiac arrest and sudden cardiac death, prevention and first aid]. Vestnik aritmologii, 2017, vol. 89, pp. 2-104. (in Russian).
6. Tereshchenko S.N., Galyavich A.S., Uskach T.M., et al. Hronicheskaya serdechnaya nedostatochnost’. Klinicheskie rekomendacii 2020. [2020 Clinical practice guidelines for chronic heart failure] Ros kardiolog zhurnal, 2020, vol. 25(11), pp. 311-374. doi:10.15829/1560-4071-2020-4083. (in Russian).
7. Xanthakis V., Enserro D.M., Larson M.G., Wollert K.C., Januzzi J.L., Levy D., et al. Prevalence, Neurohormonal Correlates, and Prognosis of Heart Failure Stages in the Community. JACC: Heart Failure, 2016, vol. 4(10), pp. 808-815. doi: 10.1016/j.jchf.2016.05.001.
8. Fomin I.V. Hronicheskaya serdechnaya nedostatochnost v Rossijskoj Federacii: chto segodnya my znaem i chto dolzhny delat [Chronic heart failure in the Russian Federation: what we know today and what we should do]. Ros kardiolog zhurnal, 2016, vol. 8(136), pp. 7-13. (in Russian).
9. Ponikowski P., Voors A.А., Anker S.D., et al. Rekomendacii ESC po diagnostike i lecheniyu ostroj i hronicheskoj serdechnoj nedostatochnosti 2016 [2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure]. Ros kardiolog zhurnal, 2017, vol. 22(1), pp. 7-81. (in Russian).
10. Korobkova I.I. Vozmozhnosti tradicionnogo rentgenologicheskogo issledovaniya v sovremennoj diagnostike serdechno-sosudistyh zabolevanij [Possibilities of traditional X-ray examination in modern diagnostics of cardiovascular diseases]. AtmosferA, 2006, no. 1, pp. 7-14. (in Russian).
11. Ponikowski P., Voors A.A., Anker S.D., et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J, 2016, vol. 37, no. 27, pp. 2129-2200. doi: 10.1093/eurheartj/ehw128.
12. Mor-Avi V., Lang R.M., Badano L.P., et al. Current and evolving echocardiographic techniques forthe quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodologyand indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr, 2011, vol. 12(3), 167-205. doi: 10.1093/ejechocard/jer021.
13. Berstein LL, Novikov VI, Grishkin YuN. Prognoz uvelicheniya konechno-sistolicheskogo indeksa levogo zheludochka posle ostrogo infarkta miokarda [The forecast of left ventricle end-systolic index increase after acute myocardial infarction]. Ultrasound Functional Diagnostics, 2007, no. 6, pp. 87-96. (in Russian).
14. Krikunov P.V., Vasyuk Yu. A., Krikunova O.V. Prognosticheskaya znachimost ekhokardiografii posle ostrogo infarkta miokarda. Chast 1 [Predictive value of echocardiog - raphy in post myocardial infarction setting. Part 1]. Ros kardiolog zhurnal, 2017, 22(12), pp. 120-128. (in Russian).
15. Naumenko E.P., Adzeriho I.E. Tkanevaya dopplerografiya: principy i vozmozhnosti metoda (obzor literatury) [Doppler tissue imaging: principles and possibilities of the method (literature review)]. Problemy zdorovya i ekologii, 2012, vol. 4(34), pp. 17-22. (in Russian).
16. Kadappu K.K., Thomas L. Tissue Doppler imaging in echocardiography: value and limitations. Heart Lung Circ, 2015, vol. 24(3), pp. 224-233. doi: 10.1016/j.hlc.2014.10.003.
17. Mondillo S., Galderisi M., Mele D., et al. Speckle-tracking echocardiography: a new technique for assessing myocardial function. J Ultrasound Med, 2011, vol. 30(1), pp. 71-83. doi: 10.7863/jum.2011.30.1.71.
18. Nikiforov V.S., Nikishchenkova I.V. Covremennye vozmozhnosti speckle tracking ekhokardiografiii v klinicheskoj praktike [Modern possibilities of speckle tracking echocardiography in clinical practice]. Rac farmakoter kardiologii, 2017, vol. 13(2), pp. 248-255. doi: 10.20996/1819-6446-2017-13-2-248-255. (in Russian).
19. Tereshchenko A.S., Zhirov I.V., Savchenko A.P., Cherkavskaya O.V. Bazovye principy ocenki koronarnogo krovotoka dlya obosnovaniya novyh diagnosticheskih metodik. Chast 1. Ponyatie o frakcionnom rezerve krovotoka [Basic evaluation principles of coronary blood flow to establish new diagnostic procedures.part 1. Fractional reserve of blood flow conception]. Vest rentgenol radiol, 2012, no. 2, pp. 44-51. (in Russian).
20. Karpova A.A., Rejder T.N. Osobennosti porazheniya koronarnogo rusla u pacientov s multifokalnym aterosklerozom v sochetanii s hronicheskoj obstruktivnoj boleznyu legkih [Features of coronary lesion in patients with multifocal atherosclerosis in combination with chronic obstructive pulmonary disease]. Fundamentalnye issledovaniya, 2014, no. 4-2, pp. 286-290. (in Russian).
21. Ostryj infarkt miokarda s podemom segmenta ST. Klinicheskie rekomendacii Associaciya serdechno-sosudistyh hirurgov Rossii [Acute ST-segment elevation myocardial infarction. Clinical guidelines Russian Association of Cardiovascular Surgeons]. M, 2020, pp. 104. (in Russian).
22. Kern M.J., Lerman A., Bech J.W.et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory. A scientific statement from the American Heart Association committee on diagnostic and interventional cardiac catheterization council on clinical cardiology. Circulation, 2006, vol. 114(12), pp. 1321-1341. doi: 10.1161/CIRCULATIONAHA.106.177276.
23. Neng D., Wenliang C., Lu L., Wen Z., et al. Diagnostic Value of Angiography-Derived IMR for Coronary Microcirculation and Its Prognostic Implication After PCI. Front Cardiovasc Med, 2021, vol. 15(8), pp. 735743. doi: 10.3389/fcvm.2021.735743. Collection 2021.
24. Dragana I.S., Jankovic S. Multispiralnaya kompyuternaya tomografiya-koronarog ra fiya u bolnyh so stenokardiej napryazheniya [Multislice computed tomography coronary angiography in patients with angina pectoris]. Ros kardiolog zhurnal, 2016, vol. 4(132), pp. 165-168. doi: 10.15829/1560-4071-2016-4-eng-165-168. (in Russian).
25. Delyan A.M., Frolova E.B., Tsybulkin N.A., Malov А.А. Magnetic resonance imaging in emergency cardiology: an introduction of modern diagnostic method. Bul Contem Clin Med, 2018, vol. 11(5), pp. 104-109. doi: 10.20969/VSKM.2018.11(5).104-109.
26. Song Y., Zhang R-F., Liu Y. 2D-STI combined with gated 99Tcm-MIBI MPI for the diagnosis of myocardial ischemia in hypercholesterolemia patients. Exp Ther Med, 2018, vol. 15(5), pp. 4594. doi: 10.3892/etm.2018.5975.
27. Liu Y., Li C., Guo S., Song Y., Zhao Y. A novel level set method for segmentation of left and right ventricles from cardiac MR images. Annu Int Conf IEEE Eng Med Biol Soc, 2014, pp. 4719-4722. doi: 10.1109/EMBC.2014.6944678.
28. Timofeeva V.V., Mironova N.A., Stukalova O.V., Golitsyn S.P. Vozmozhnost ispolzovaniya magnitno-rezonansnoj tomografii serdca i metodov elektrokardiografii v stratifikacii riska vnezapnoj aritmicheskoj smerti [Cardiac magnetic resonance imaging and electrocardiography in sudden arrhythmic death risk stratification]. Kardiologicheskij vestnik, 2021, vol. 16(1), pp. 34-42. doi: 10.17116/ Cardiobulletin20211601134. (in Russian).
29. Strauss H.W., Miller D.D., Wittry M.D., et al. Procedure Guideline for Myocardial Perfusion Imaging 3.3. J Nucl Med Technol, 2008, vol. 36(3), pp. 155-161. doi: 10.2967/jnmt.108.056465.
30. Yoshinaga K., Tamaki N. Imaging myocardial metabolism. Curr Opin Biotechnol, 2007, vol 18(1), pp. 52-59. doi: 10.1016/j.copbio.2006.11.003.
31. Sergienko V. B., Babaev F. Z. Pozitronnaya emissionnaya tomografiya v ocenke metabolizma miokarda [Possibilites of pet for myocardial metabolism estimation]. Ateroskleroz i dislipidemii, 2011, no. 2, pp. 26-31. (in Russian).
32. Ukkonen H., Beanlands R. Oxidative metabolism and cardiac efficiency. In Wahl R.L. Philadelphia P.A. eds. Principles and Practice of Positron Emission Tomography. Lippincott Williams and Wilkins, 2002, pp. 351-367.
33. Ryzhkova D.V., Nifontov E.M., Tyutin L.A., Zykov E.M. Pozitronnaya emissionnaya tomografiya v diagnostike ishemicheskoj bolezni serdca (obzor literatury) [Positron emission tomography in the diagnosis of coronary heart disease (literature review)]. Consilium Medicum, 2007, no. 4, pp. 17-22. (in Russian).
34. Kitsiou A.N., Bacharach S.L., Bartlett M.L., et al. 13N-ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization. J Am Coll Cardiol, 1999, vol. 33(3), pp. 678-686. doi: 10.1016/ s0735-1097(98)00630-5.
35. Strauss H.W., Miller D.D., Wittry M.D. Procedure Guideline for Myocardial Perfusion Imaging 3.3. J Nucl Med Technol, 2008, vol. 36(30, pp. 155-161. doi: 10.2967/jnmt.108.056465.
